Resources from the same session
Pathological subgroups and molecular characterisation
Presenter: Sabine Tejpar
Session: Precision cancer medicine in metastatic colorectal cancer
Cell free tumour DNA: Yet a role in treatment monitoring of mCRC?
Presenter: Karen-Lise Spindler
Session: Precision cancer medicine in metastatic colorectal cancer
Resources:
Slides
Webcast
Novel therapeutic approaches for specific (rare) subtypes
Presenter: Tim Maughan
Session: Precision cancer medicine in metastatic colorectal cancer
Resources:
Slides
Webcast
Immunotherapy: Checkpoint inhibitors and beyond
Presenter: Aurelien Marabelle
Session: Precision cancer medicine in metastatic colorectal cancer
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Tim Maughan
Session: Precision cancer medicine in metastatic colorectal cancer
Resources:
Slides
Webcast